Emergent BioSolutions Reports Third Quarter 2024 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) | Delayed: 6.44 -0.37 (5.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.81 | 52 Week High | $44.38 | |||
| Open | $6.82 | 52 Week Low | $24.47 | |||
| Day High | $6.88 | P/E | 322.00 | |||
| Day Low | $6.37 | EPS | $0.02 | |||
| Volume | 953,918 | |||||
